(Mark One)
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended June 30, 2012
|
|
OR
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934
|
For the transition period from ____________ to ____________
|
Delaware
|
32-0186005
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Large accelerated filer o
|
Accelerated filer o
|
|
Non-Accelerated filer o
|
Smaller reporting company x
|
|
(Do not check if a smaller reporting company
|
Page
|
|||||
PART I.—FINANCIAL INFORMATION
|
|||||
Item 1.
|
Financial Statements
|
||||
Consolidated Balance Sheets
|
2
|
||||
Consolidated Statements of Operations - unaudited
|
3
|
||||
Consolidated Statement of Equity –unaudited
|
4 | ||||
Consolidated Statement of Cash Flows - unaudited
|
5
|
||||
Notes to Consolidated Financial Statements
|
|
6
|
|||
Item 2.
|
Management’s Discussion and Analysis of Financial Conditions and Results of Operations
|
|
20
|
||
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risks
|
|
24
|
||
Item 4.
|
Controls and Procedures
|
|
24
|
||
PART II—OTHER INFORMATION
|
|||||
Item 1.
|
Legal Proceedings
|
||||
Item 1A.
|
Risk Factors
|
|
25
|
||
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
25
|
||
Item 3.
|
Defaults Upon Senior Securities
|
25
|
|||
Item 4.
|
Mine Safety Disclosures
|
25
|
|||
Item 5.
|
Other Information
|
25
|
|||
Item 6.
|
Exhibits
|
|
25
|
||
SIGNATURE
|
|
26
|
Progressive Care Inc. and Subsidiaries
|
||||||||
Consolidated Balance Sheets
|
||||||||
(unaudited) | ||||||||
December 31, 2011
|
||||||||
June 30, 2012
|
(As Restated)
|
|||||||
(unaudited) | ||||||||
Assets
|
||||||||
Current Assets
|
||||||||
Cash
|
$ | 107,976 | $ | 88,874 | ||||
Accounts receivable - net
|
1,285,757 | 1,006,835 | ||||||
Inventory
|
299,754 | 248,678 | ||||||
Prepaids
|
13,395 | 21,741 | ||||||
Total Current Assets
|
1,706,882 | 1,366,128 | ||||||
Property and equipment - net
|
283,808 | 276,795 | ||||||
Other Assets
|
||||||||
Debt issue costs - net
|
145,413 | 22,259 | ||||||
Deposits
|
43,746 | 44,741 | ||||||
Total Other Assets
|
189,159 | 67,000 | ||||||
Total Assets
|
$ | 2,179,849 | $ | 1,709,923 | ||||
Liabilities and Stockholders' Equity
|
||||||||
Current Liabilities
|
||||||||
Cash overdraft
|
$ | - | $ | 71,380 | ||||
Accounts payable and accrued liabilities
|
337,823 | 248,785 | ||||||
Deferred rent payable
|
32,387 | 17,535 | ||||||
Income taxes payable
|
42,656 | 42,656 | ||||||
Debt - net
|
398,024 | 87,767 | ||||||
Debt - related party
|
- | 73,329 | ||||||
Accrued interest payable - related party
|
- | 24,732 | ||||||
Derivative liability
|
228,208 | - | ||||||
Total Current Liabilities
|
1,039,098 | 566,184 | ||||||
Long Term Liabilities
|
||||||||
Debt
|
150,000 | 150,000 | ||||||
Stockholders' Equity
|
||||||||
Common stock, par value $0.0001; 100,000,000 shares authorized
|
||||||||
38,314,617 and 36,596,617 issued and outstanding and
|
||||||||
38,066,830 and 36,348,830 issued and outstanding, respectively
|
3,831 | 3,807 | ||||||
Additional paid in capital
|
136,885 | (88,581 | ) | |||||
Retained Earnings
|
850,035 | 1,078,513 | ||||||
Total Stockholders' Equity
|
990,751 | 993,739 | ||||||
Total Liabilities and Stockholders' Equity
|
$ | 2,179,849 | $ | 1,709,923 |
Progressive Care Inc. and Subsidiaries
|
||||||||||||||||
Consolidated Statements of Operations
|
||||||||||||||||
(Unaudited)
|
||||||||||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
(As Restated)
|
(As Restated)
|
|||||||||||||||
Sales - net
|
$ | 2,542,478 | $ | 1,897,289 | $ | 4,970,006 | $ | 3,769,909 | ||||||||
Cost of sales
|
1,744,855 | 880,752 | 3,587,871 | 1,831,953 | ||||||||||||
Gross profit
|
797,623 | 1,016,537 | 1,382,135 | 1,937,956 | ||||||||||||
Selling, general and administrative expenses
|
857,431 | 1,079,100 | 1,609,462 | 1,973,889 | ||||||||||||
Loss from operations
|
(59,808 | ) | (62,563 | ) | (227,327 | ) | (35,933 | ) | ||||||||
Other Income (Expense)
|
||||||||||||||||
Change in fair value of derivative liability
|
15,945 | - | 15,945 | - | ||||||||||||
Gain on debt forgiveness
|
69,298 | - | 69,298 | 12,585 | ||||||||||||
Interest expense
|
(78,898 | ) | (1,538 | ) | (86,394 | ) | (12,571 | ) | ||||||||
Total other income (expense) - net
|
6,345 | (1,538 | ) | (1,151 | ) | 14 | ||||||||||
Loss from operations before provision for income taxes
|
(53,463 | ) | (64,101 | ) | (228,478 | ) | (35,919 | ) | ||||||||
Provision for income taxes (benefit)
|
||||||||||||||||
Current income tax
|
- | (49,067 | ) | - | - | |||||||||||
Deferred income tax
|
- | 26,100 | - | - | ||||||||||||
Total income tax benefit - net
|
- | (22,967 | ) | - | - | |||||||||||
Net loss
|
$ | (53,463 | ) | $ | (41,134 | ) | $ | (228,478 | ) | $ | (35,919 | ) | ||||
Basic and diluted net loss per common share
|
(0.00 | ) | (0.00 | ) | (0.01 | ) | (0.00 | ) | ||||||||
Weighted average number of common shares outstanding
|
||||||||||||||||
during the period - basic and diluted
|
36,514,906 | 37,209,546 | 36,436,786 | 36,478,861 |
Progressive Care Inc. and Subsidiaries
|
||||||||||||||||||||
Consolidated Statement of Stockholders' Equity
|
||||||||||||||||||||
Years Ended December 31, 2011 and 2010 and the Six Months Ended June 30, 2012
|
||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Common Stock
|
Additional
|
Total
|
||||||||||||||||||
$0.0001 Par Value
|
Paid-in
|
Retained
|
Stockholders'
|
|||||||||||||||||
Shares
|
Amount
|
Capital
|
Earnings
|
Equity
|
||||||||||||||||
Balance, December 31, 2010 (as restated)
|
35,280,000 | 3,528 | (1,141,029 | ) | 1,301,600 | 164,099 | ||||||||||||||
Issuance of common stock for services rendered
|
302,261 | 30 | 83,213 | - | 83,243 | |||||||||||||||
Issuance of common stock for services rendered - related parties
|
1,385,596 | 139 | 524,861 | - | 525,000 | |||||||||||||||
Issuance of common stock in connection with the conversions of debt and accrued interest
|
1,098,973 | 110 | 439,479 | - | 439,589 | |||||||||||||||
Issuance of warrants as debt issue cost - related party
|
- | - | 4,895 | - | 4,895 | |||||||||||||||
Net loss - 2011
|
- | - | - | (223,087 | ) | (223,087 | ) | |||||||||||||
Balance, December 31, 2011 (as restated)
|
38,066,830 | 3,807 | (88,581 | ) | 1,078,513 | 993,739 | ||||||||||||||
Issuance of common stock for debt issue costs
|
196,078 | 19 | 99,981 | - | 100,000 | |||||||||||||||
Issuance of common stock for services rendered
|
30,000 | 3 | 14,497 | - | 14,500 | |||||||||||||||
Issuance of common stock for services rendered - related party
|
21,709 | 2 | 9,998 | - | 10,000 | |||||||||||||||
Gain on debt forgiveness - related party
|
- | - | 100,990 | - | 100,990 | |||||||||||||||
Net loss for the six months ended June 30, 2012
|
- | - | - | (228,478 | ) | (228,478 | ) | |||||||||||||
Balance, June 30, 2012 (Unaudited)
|
38,314,617 | $ | 3,831 | $ | 136,885 | $ | 850,035 | $ | 990,751 |
Progressive Care Inc. and Subsidiaries
|
||||||||
Consolidated Statements of Cash Flows
|
||||||||
(Unaudited)
|
||||||||
Six Months Ended
|
||||||||
June 30, 2012
|
June 30, 2011
|
|||||||
(As Restated)
|
||||||||
Cash Flows From Operating Activities:
|
||||||||
Net loss
|
$ | (228,478 | ) | $ | (35,919 | ) | ||
Adjustments to reconcile net loss to net cash
|
||||||||
provided by (used in) operating activities:
|
||||||||
Depreciation
|
128,574 | 40,556 | ||||||
Bad debt
|
38,311 | - | ||||||
Stock-based compensation
|
14,500 | 335,845 | ||||||
Stock-based compensation - related parties
|
10,000 | - | ||||||
Amortization of debt issue costs and debt discount
|
67,485 | - | ||||||
Change in fair value of derivative liability
|
(15,945 | ) | - | |||||
Gain on debt forgiveness
|
(69,298 | ) | - | |||||
Changes in operating assets and liabilities:
|
||||||||
(Increase) decrease in:
|
||||||||
Accounts receivable
|
(317,233 | ) | (228,455 | ) | ||||
Inventory
|
(51,076 | ) | 67,568 | |||||
Prepaids
|
8,346 | (4,985 | ) | |||||
Deposits
|
995 | (35,704 | ) | |||||
Increase (decrease) in:
|
||||||||
Accounts payable and accrued liabilities
|
217,745 | 100,073 | ||||||
Deferred rent
|
14,852 | 8,733 | ||||||
Accrued interest payable - related party
|
2,929 | (2,897 | ) | |||||
Net Cash Provided by (Used in) Operating Activities
|
(178,293 | ) | 244,815 | |||||
Cash Flows From Investing Activities:
|
||||||||
Purchase of property and equipment
|
(135,587 | ) | (128,766 | ) | ||||
Net Cash Used in Investing Activities
|
(135,587 | ) | (128,766 | ) | ||||
Cash Flows From Financing Activities:
|
||||||||
Cash overdraft
|
(71,380 | ) | - | |||||
Proceeds from issuance of debt
|
540,000 | - | ||||||
Debt issue costs
|
(52,500 | ) | - | |||||
Repayment of debt
|
(83,138 | ) | (71,780 | ) | ||||
Net Cash Provided by (Used in) Financing Activities
|
332,982 | (71,780 | ) | |||||
Net increase in cash
|
19,102 | 44,269 | ||||||
Cash at beginning of period
|
88,874 | 204,336 | ||||||
Cash at end of period
|
$ | 107,976 | $ | 248,605 | ||||
Supplemental disclosures of cash flow information:
|
||||||||
Cash paid for interest
|
$ | 12,062 | $ | 2,480 | ||||
Cash paid for taxes
|
$ | - | $ | - | ||||
Supplemental disclosures of non-cash financing activities:
|
||||||||
Conversion of accounts payable to notes
|
$ | 122,176 | $ | - | ||||
Debt discount recorded on convertible debt accounted for as a derivative liability
|
$ | 244,153 | $ | - | ||||
Issuance of common stock for debt issue costs
|
$ | 100,000 | $ | - | ||||
Gain on debt forgiveness - related party
|
$ | 100,990 | $ | - |
December 31, 2011
|
||||||||||||
As Originally Reported
|
Adjustments
|
As Restated
|
||||||||||
(unaudited) | ||||||||||||
Assets
|
||||||||||||
Current Assets
|
||||||||||||
Cash
|
$ | 88,874 | $ | - | $ | 88,874 | ||||||
Accounts receivable - net
|
1,006,835 | - | 1,006,835 | |||||||||
Inventory
|
248,678 | - | 248,678 | |||||||||
Prepaids
|
21,741 | - | 21,741 | |||||||||
Total Current Assets
|
1,366,128 | - | 1,366,128 | |||||||||
Property and equipment - net
|
276,795 | - | 276,795 | |||||||||
Other Assets
|
||||||||||||
Intangibles - net
|
1,574,663 | (1,574,663 | ) | - | ||||||||
Goodwill
|
1,348,402 | (1,348,402 | ) | - | ||||||||
Debt issue costs
|
22,259 | - | 22,259 | |||||||||
Deposits | 44,741 | - | 44,741 | |||||||||
Total Other Assets
|
2,990,065 | (2,923,065 | ) | 67,000 | ||||||||
Total Assets
|
$ | 4,632,988 | $ | (2,923,065 | ) | $ | 1,709,923 | |||||
Liabilities and Stockholders' Equity
|
||||||||||||
Current Liabilities
|
||||||||||||
Cash overdraft
|
$ | 71,380 | $ | - | $ | 71,380 | ||||||
Accounts payable and accrued liabilities
|
248,786 | - | 248,785 | |||||||||
Deferred rent payable
|
17,535 | - | 17,535 | |||||||||
Income taxes payable
|
42,656 | - | 42,656 | |||||||||
Notes payable
|
87,767 | - | 87,767 | |||||||||
Notes payable - related party
|
73,329 | - | 73,329 | |||||||||
Accrued interest payable - related party
|
24,732 | - | 24,732 | |||||||||
Total Current Liabilities
|
566,185 | - | 566,184 | |||||||||
Long Term Liabilities
|
||||||||||||
Convertible Debt - note payable
|
150,000 | - | 150,000 | |||||||||
Total Long Term Liabilities
|
150,000 | - | 150,000 | |||||||||
Stockholders' Equity
|
||||||||||||
Common stock, par value $0.0001; 100,000,000 shares authorized
|
||||||||||||
38,066,830 and 36,348,830 issued and outstanding (2011); and
|
||||||||||||
35,280,000 and 33,562,000 shares issued and outstanding (2010)
|
3,807 | - | 3,807 | |||||||||
Additional paid in capital
|
6,278,571 | (6,367,152 | ) | (88,581 | ) | |||||||
Accumulated deficit
|
(2,365,574 | ) | 3,444,087 | 1,078,513 | ||||||||
Total Stockholders' Equity
|
3,916,804 | (2,923,065 | ) | 993,739 | ||||||||
Total Liabilities and Stockholders' Equity
|
$ | 4,632,989 | $ | (2,923,065 | ) | $ | 1,709,923 |
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
June 30, 2011
|
June 30, 2011
|
|||||||||||||||||||||||
As Originally Reported
|
Adjustments
|
As Restated
|
As Originally Reported
|
Adjustments
|
As Restated
|
|||||||||||||||||||
Sales - net
|
$ | 1,897,289 | $ | - | $ | 1,897,289 | $ | 3,769,909 | $ | - | $ | 3,769,909 | ||||||||||||
Cost of sales
|
880,752 | - | 880,752 | 1,831,953 | - | 1,831,953 | ||||||||||||||||||
Gross profit
|
1,016,537 | - | 1,016,537 | 1,937,956 | - | 1,937,956 | ||||||||||||||||||
Selling, general and administrative expenses
|
1,139,734 | (60,635 | ) | 1,079,100 | 2,094,492 | (120,603 | ) | 1,973,889 | ||||||||||||||||
Loss from operations
|
(123,197 | ) | 60,635 | (62,563 | ) | (156,536 | ) | 120,603 | (35,933 | ) | ||||||||||||||
Other Income (Expense)
|
||||||||||||||||||||||||
Gain on debt settlement - former related party
|
- | - | - | 12,585 | - | 12,585 | ||||||||||||||||||
Interest expense
|
(1,538 | ) | - | (1,538 | ) | (12,571 | ) | - | (12,571 | ) | ||||||||||||||
Total other income - net
|
(1,538 | ) | - | (1,538 | ) | 14 | - | 14 | ||||||||||||||||
Losses from continuing operations before provision for income taxes
|
(124,735 | ) | 60,635 | (64,101 | ) | (156,522 | ) | 120,603 | (35,919 | ) | ||||||||||||||
Provision for income taxes (benefit)
|
||||||||||||||||||||||||
Current income tax
|
(49,067 | ) | - | (49,067 | ) | - | - | - | ||||||||||||||||
Deferred income tax
|
26,100 | - | 26,100 | - | - | - | ||||||||||||||||||
Total income tax benifit - net
|
(22,967 | ) | - | (22,967 | ) | - | - | - | ||||||||||||||||
Net loss
|
$ | (101,768 | ) | $ | 60,635 | $ | (41,134 | ) | $ | (156,522 | ) | $ | 120,603 | $ | (35,919 | ) | ||||||||
Basic and diluted loss per share:
|
(0.00 | ) | (0.00 | ) | (0.00 | ) | (0.00 | ) | (0.00 | ) | (0.00 | ) | ||||||||||||
Weighted average number of common shares outstanding
|
||||||||||||||||||||||||
during the period - basic and diluted
|
37,209,546 | 37,209,546 | 36,478,861 | 36,478,861 |
June 30, 2011
|
||||||||||||
As Originally Reported
|
Adjustments
|
As Restated
|
||||||||||
Cash Flows From Operating Activities:
|
||||||||||||
Net loss
|
$ | (156,522 | ) | $ | 120,603 | $ | (35,919 | ) | ||||
Adjustments to reconcile net loss to net cash
|
||||||||||||
provided by (used in) operating activities:
|
||||||||||||
Depreciation
|
40,556 | - | 40,556 | |||||||||
Stock-based compensation
|
335,845 | - | 335,845 | |||||||||
Amortization of intangibles
|
120,603 | (120,603 | ) | - | ||||||||
Changes in operating assets and liabilities:
|
||||||||||||
Accounts receivable
|
(228,455 | ) | - | (228,455 | ) | |||||||
Inventory
|
67,568 | - | 67,568 | |||||||||
Prepaids
|
(4,985 | ) | - | (4,985 | ) | |||||||
Deposits
|
(35,704 | ) | - | (35,704 | ) | |||||||
Accounts payable and accrued liabilities
|
100,073 | - | 100,073 | |||||||||
Deferred rent
|
8,733 | - | 8,733 | |||||||||
Accrued interest payable - related parties
|
(2,897 | ) | - | (2,897 | ) | |||||||
Net Cash Provided by Operating Activities
|
244,815 | - | 244,815 | |||||||||
Cash Flows From Investing Activities:
|
||||||||||||
Purchase of property and equipment
|
(128,766 | ) | - | (128,766 | ) | |||||||
Net Cash Used in Investing Activities
|
(128,766 | ) | - | (128,766 | ) | |||||||
Cash Flows From Financing Activities:
|
||||||||||||
Repayment of debt
|
(71,780 | ) | - | (71,780 | ) | |||||||
Net Cash Used in Financing Activities
|
(71,780 | ) | - | (71,780 | ) | |||||||
Net increase in cash
|
$ | 44,269 | $ | - | $ | 44,269 | ||||||
Cash at beginning of period
|
204,336 | - | 204,336 | |||||||||
Cash at end of period
|
$ | 248,605 | $ | - | $ | 248,605 | ||||||
Supplemental disclosures of cash flow information:
|
||||||||||||
Cash paid for interest
|
$ | 2,480.00 | $ | 2,480.00 | ||||||||
Cash paid for taxes
|
$ | - | $ | - |
Insurance
Provider
|
Six months ended
June 30, 2012
|
Six months ended
June 30, 2011
|
||
A
|
20%
|
11%
|
||
B
|
15%
|
13%
|
||
C
|
13%
|
1%
|
||
D
|
13%
|
-
|
||
E
|
-
|
17%
|
●
|
Level 1 - |
Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
|
●
|
Level 2 - |
Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
|
●
|
Level 3 - |
Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
|
June 30, 2012 | December 31, 2011 | |||||||
Derivative Liabilities (Level 2)
|
$ | 228,208 | $ | - |
(i)
|
Pharmacy
|
(ii)
|
Durable Medical Equipment
|
Vendor
|
Six months ended
June 30, 2012
|
Six months ended
June 30, 2011
|
||
A
|
65%
|
6%
|
||
B
|
15%
|
35%
|
||
C
|
1%
|
35%
|
Six months ended
June 30, 2012
|
Six months ended
June 30, 2011
|
||||||
$ |
14,200
|
$ |
49,180
|
Shares
|
||||
Convertible debt – face amount of $150,000; fixed conversion price; $0.40
|
375,000 | |||
Convertible debt – face amount of $500,000; variable conversion price; $0.40
|
1,253,133 | |||
Common stock warrants - 15,000; exercise price of $0.40
|
15,000 | |||
Total common stock equivalents
|
1,643,133 |
June 30, 2012
|
December 31, 2011
|
|||||||
Gross accounts receivable
|
$ | 1,353,439 | $ | 1,057,696 | ||||
Allowance
|
(67,682 | ) | (50,861 | ) | ||||
Accounts receivable – net
|
$ | 1,285,757 | $ | 1,006,835 |
June 30, 2012
|
December 31, 2011
|
Estimated Useful Life
|
|||||||
DME rental equipment
|
$ | 260,815 | $ | 223,685 |
Life of the lease
|
||||
Leasehold improvements and fixtures
|
181,536 | 139,008 |
5 years
|
||||||
Vehicles
|
90,046 | 90,046 |
3 years
|
||||||
Computer equipment and software
|
56,407 | 56,407 |
3-5 years
|
||||||
Furniture and equipment
|
30,575 | 28,486 |
13 months
|
||||||
Total
|
619,379 | 537,632 | |||||||
Less: accumulated amortization/depreciation
|
(335,571 | ) | (260,837 | ) | |||||
Property and equipment – net
|
$ | 283,808 | $ | 276,795 |
June 30, 2012
|
December 31, 2011
|
|||||||
A. Convertible debt - Secured
|
$ | 500,000 | $ | - | ||||
Less: debt discount
|
(206,014 | ) | - | |||||
Convertible debt - net
|
293,986 | - | ||||||
B. Convertible debt - Unsecured
|
150,000 | 150,000 | ||||||
C. Note - Secured
|
29,920 | - | ||||||
D. Notes – Unsecured
|
74,118 | 161,096 | ||||||
Total debt
|
$ | 548,024 | $ |
311,096
|
||||
Current portion
|
$ | 398,024 | $ |
161,096
|
||||
Long term portion
|
$ | 150,000 | $ | 150,000 |
Balance, December 31, 2011
|
$
|
-
|
||
Reclassification from accounts payable to notes payable
|
51,290
|
|||
Repayments
|
(21,370
|
)
|
||
Balance, June 30, 2012
|
$
|
29,920
|
Balance, December 31, 2011
|
$
|
161,0966
|
||
Reclassification from accounts payable to notes payable
|
70,8866
|
|||
Additional borrowings
|
40,000 | |||
Repayments
|
(61,7688
|
)
|
||
Debt forgiveness
|
(62,7677
|
)
|
||
Debt forgiveness – related party
|
(73,3299
|
)
|
||
Balance, June 30, 2012
|
$
|
74,1188
|
June 30, 2012
|
December 31, 2011
|
|||||||
Debt issue costs
|
$ | 175,395 | $ | 22,895 | ||||
Accumulated amortization of debt issue costs
|
(29,982 | ) | (636 | ) | ||||
Debt issue costs – net
|
$ | 145,413 | $ | 22,259 |
Year
|
Amount
|
|||
2012 (6 months remaining)
|
$ |
80,724
|
||
2013
|
57,769
|
|||
2014
|
6,920
|
|||
$
|
145,413
|
June 30, 2012
|
June 30, 2012
|
|||||||
Debt discount
|
$ | 244,153 | $ | - | ||||
Accumulated amortization of debt discounts
|
(38,139 | ) | - | |||||
Debt discount – net
|
$ | 206,014 | $ | - |
Derivative liability - December 31, 2011
|
$ | - | ||
Fair value at the commitment date for debt instruments
|
244,153 | |||
Fair value mark to market adjustment for debt instruments
|
(15,945 | ) | ||
Derivative liability – June 30,2012
|
$ | 228,208 |
Commitment Date
|
Re-measurement Date
|
|||||||
Expected dividends
|
0 | % | 0 | % | ||||
Expected volatility
|
119 | % | 121 | % | ||||
Expected term:
|
12 months
|
10 months
|
||||||
Risk free interest rate
|
0.18 | % | 0.19 | % |
Number
of Warrants
|
Weighted Average
Exercise Price
|
||||||||
Balance at December 31, 2011
|
$ | 15,000 | $ | 0.40 | |||||
Granted
|
- | - | |||||||
Exercised
|
- | - | |||||||
Forfeited
|
- | - | |||||||
Balance at June 30, 2012
|
$ | 15,000 | $ | 0.40 |
Exercise Price |
Warrants
Outstanding
|
Warrants
Exercisable
|
Weighted Average
Remaining
Contractual Life
|
Aggregate
Intrinsic Value
|
|||||||||||
$ | 0.40 | 15,000 | 15,000 |
2.41 years
|
$ | 300 |
Year
|
Amount
|
|||
2012 (6 months remaining)
|
108,000 | |||
2013
|
227,000 | |||
2014
|
216,000 | |||
2015
|
222,000 | |||
2016
|
230,000 | |||
Thereafter
|
763,000 | |||
$ | 1,766,000 |
Accrued Income
Tax Payable
|
Deferred Tax
Assets
|
|||||||
Balance, December 31, 2010
|
$ | 20,203 | $ | 18,473 | ||||
Changes in the first quarter of 2011
|
28,864 | 7,627 | ||||||
Balance, March 31, 2011
|
49,067 | 26,100 | ||||||
Changes in the second quarter of 2011
|
(49,067 | ) | (26,100 | ) | ||||
Balance, June 30, 2011
|
- | - |
●
|
increasing it sales presence in the community by sponsoring health related events
|
●
|
hiring additional sales personnel to target additional market segments
|
●
|
seeking additional third party debt and/or equity financing
|
·
|
the diversification of our product base by selling and marketing DME outside the scope of the review process;
|
·
|
an increase in compliance protocols to increase the likelihood of payment without review;
|
·
|
the improvement of the documentation process between us and Medicare, patients, doctors, and referral sources to ensure timely receipt of supporting documentation to substantiate billing claims; and
|
·
|
an increase in the training, productivity and efficiency of our sales staff to streamline overall processes.
|
Three Months Ended
|
||||||||||||||||||||||||
June 30, 2012
|
June 30, 2011
|
|||||||||||||||||||||||
Dollars
|
% of
Revenue
|
Dollars
|
% of
Revenue
|
$ change
|
% change
|
|||||||||||||||||||
Total revenues - net
|
$ | 2,542,478 | 100 | % | $ | 1,897,289 | 100 | % | $ | 645,189 | 34 | % | ||||||||||||
Total cost of sales
|
1,744,855 | 69 | % | 880,752 | 46 | % | 864,103 | 98 | % | |||||||||||||||
Total gross margin
|
797,623 | 31 | % | 1,016,537 | 54 | % | (218,914 | ) | -22 | % | ||||||||||||||
Operating expenses
|
857,431 | 34 | % | 1,079,100 | 57 | % | (221,669 | ) | -21 | % | ||||||||||||||
Other income (expense)
|
6,345 | 0 | % | (1,538 | ) | 0 | % | 7,883 | -513 | % | ||||||||||||||
Operating loss
|
(53,463 | ) | -2 | % | (64,101 | ) | -3 | % | 10,638 | -17 | % | |||||||||||||
Income tax expense
|
- | (22,967 | ) | $ | 22,967 | -100 | % | |||||||||||||||||
Net loss
|
(53,463 | ) | -2 | % | (41,134 | ) | -2 | % | (12,329 | ) |
Three Months Ended
|
||||||||||||||||||||||||
June 30, 2012
|
June 30, 2011
|
|||||||||||||||||||||||
Dollars
|
% of
Revenue
|
Dollars
|
% of
Revenue
|
$ change
|
% change
|
|||||||||||||||||||
Pharmacy
|
$ | 2,209,000 | 87 | % | $ | 1,783,000 | 94 | % | $ | 426,000 | 24 | % | ||||||||||||
DME
|
$ | 333,000 | 13 | % | $ | 114,000 | 6 | % | 219,000 | 192 | % | |||||||||||||
Total Sales
|
$ | 2,542,000 | $ | 1,897,000 | $ | 645,000 | 34 | % |
Six Months Ended
|
||||||||||||||||||||||||
June 30, 2012
|
June 30, 2011
|
|||||||||||||||||||||||
Dollars
|
% of
Revenue
|
Dollars
|
% of
Revenue
|
$ change
|
% change
|
|||||||||||||||||||
Total revenues - net
|
$ | 4,970,006 | 100 | % | $ | 3,769,909 | 100 | % | $ | 1,200,097 | 32 | % | ||||||||||||
Total cost of sales
|
3,587,871 | 72 | % | 1,831,953 | 49 | % | 1,755,918 | 96 | % | |||||||||||||||
Total gross margin
|
1,382,135 | 28 | % | 1,937,956 | 51 | % | (555,821 | ) | -29 | % | ||||||||||||||
Operating expenses
|
1,609,462 | 32 | % | 1,973,889 | 52 | % | (364,427 | ) | -18 | % | ||||||||||||||
Other income (expense)
|
(1,151 | ) | 0 | % | 14 | 0 | % | (1,165 | ) | -8321 | % | |||||||||||||
Operating loss
|
(228,478 | ) | -5 | % | (35,919 | ) | -1 | % | (192,559 | ) | 536 | % | ||||||||||||
Income tax expense
|
- | - | $ | - | 0 | % | ||||||||||||||||||
Net loss
|
(228,478 | ) | -5 | % | (35,919 | ) | -1 | % | (192,559 | ) |
Six Months Ended
|
||||||||||||||||||||||||
June 30, 2012
|
June 30, 2011
|
|||||||||||||||||||||||
Dollars
|
% of
Revenue
|
Dollars
|
% of
Revenue
|
$ change
|
% change
|
|||||||||||||||||||
Pharmacy
|
$ | 4,281,000 | 86 | % | $ | 3,411,000 | 90 | % | $ | 870,000 | 26 | % | ||||||||||||
DME
|
$ | 689,000 | 14 | % | $ | 359,000 | 10 | % | 330,000 | 92 | % | |||||||||||||
Total Sales
|
$ | 4,970,000 | $ | 3,770,000 | $ | 1,200,000 | 32 | % |
Six Months Ended
|
||||||||
June 30, 2012
|
June 30, 2011
|
|||||||
Net change in cash from:
|
||||||||
Operating activities
|
$ | (178,293 | ) | $ | 244,815 | |||
Investing activities
|
(135,587 | ) | (128,766 | ) | ||||
Financing activities
|
332,982 | (71,780 | ) | |||||
Change in cash
|
$ | 19,102 | $ | 44,269 | ||||
Cash at end of Period
|
$ | 107,976 | $ | 248,605 |
31.1
|
Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) *
|
31.2
|
Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) *
|
32.1
|
Certification pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002 *
|
32.2
|
Certification pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002 *
|
EX-101.INS
|
XBRL Instance Document
|
EX-101.SCH
|
XBRL Taxonomy Extension Schema
|
EX-101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
EX-101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
EX-101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
EX-101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase
|
PROGRESSIVE CARE INC.
|
|||
By:
|
/s/ Avraham A. Friedman
|
||
Avraham Friedman
|
|||
President and Chief Executive Officer
|
|||
(Principal Executive Officer)
|
|||
Date: August 20, 2012
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Progressive Care Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:
|
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: August 20, 2012
|
|||
By:
|
/s/ Avraham A. Friedman
|
||
Name:
|
Avraham A. Friedman
|
||
Title:
|
President and Chief Executive Officer
|
||
(Principal Executive Officer)
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Progressive Care Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:
|
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: August 20, 2012
|
|||
By:
|
/s/ Alan Jay Weisberg
|
||
Name:
|
Alan Jay Weisberg
|
||
Title:
|
Chief Financial Officer
|
||
(Principal Financial Officer)
|
(1)
|
the accompanying Quarterly Report on Form 10-Q of the Registrant for the quarter ended June 30, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
Date: August 20, 2012
|
|||
By:
|
/s/ Avraham A. Friedman
|
||
Name:
|
Avraham A. Friedman
|
||
Title:
|
President and Chief Executive Officer
|
||
(Principal Executive Officer)
|
(1)
|
the accompanying Quarterly Report on Form 10-Q of the Registrant for the quarter ended June 30, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
Date: August 20, 2012
|
|||
By:
|
/s/ Alan Jay Weisberg
|
||
Name:
|
Alan Jay Weisberg
|
||
Title:
|
Chief Financial Officer
|
||
(Principal Financial Officer)
|
Property and Equipment (Details) (USD $)
|
6 Months Ended | |
---|---|---|
Jun. 30, 2012
|
Dec. 31, 2011
|
|
Property and equipment | ||
Total | $ 619,379 | $ 537,632 |
Less: accumulated depreciation | (335,571) | (260,837) |
Property and equipment – net | 283,808 | 276,795 |
DME rental equipment [Member]
|
||
Property and equipment | ||
Total | 260,815 | 223,685 |
Property, Plant and Equipment, Estimated Useful Lives | Life of the lease | |
Leasehold improvements and fixtures [Member]
|
||
Property and equipment | ||
Total | 181,536 | 139,007 |
Property and Equipment, Useful Life | 5 years | |
Vehicles [Member]
|
||
Property and equipment | ||
Total | 90,046 | 90,046 |
Property and Equipment, Useful Life | 3 years | |
Computer equipment and software [Member]
|
||
Property and equipment | ||
Total | 56,407 | 56,407 |
Furniture and equipment [Member]
|
||
Property and equipment | ||
Total | $ 30,575 | $ 28,486 |
Property and Equipment, Useful Life | 13 months | |
Minimum [Member] | Computer equipment and software [Member]
|
||
Property and equipment | ||
Property and Equipment, Useful Life | 3 years | |
Maximum [Member] | Computer equipment and software [Member]
|
||
Property and equipment | ||
Property and Equipment, Useful Life | 5 years |
Taxes (Details) (USD $)
|
3 Months Ended | |
---|---|---|
Jun. 30, 2011
|
Mar. 31, 2011
|
|
Summary of income tax liability | ||
Accrued Income Tax, Beginning Balance | $ 49,067 | $ 20,203 |
Changes in Accrued Income Tax | (49,067) | 28,864 |
Accrued Income Tax, Ending Balance | 49,067 | |
Deferred Tax Assets, Beginning Balance | 26,100 | 18,473 |
Changes in Deferred Tax Assets | (26,100) | 7,627 |
Deferred Tax Assets, Ending Balance | $ 26,100 |
Derivative Liabilities (Details 1)
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Commitment Date [Member]
|
|
Fair value at the commitment and re-measurement dates for the Company’s derivative liabilities | |
Expected dividends | 0.00% |
Expected volatility | 119.00% |
Expected term: | 12 months |
Risk free interest rate | 0.18% |
Re-Measurement Date [Member]
|
|
Fair value at the commitment and re-measurement dates for the Company’s derivative liabilities | |
Expected dividends | 0.00% |
Expected volatility | 121.00% |
Expected term: | 10 months |
Risk free interest rate | 0.19% |
Going Concern (Details) (USD $)
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Going Concern (Textual) | ||||
Net loss | $ (53,463) | $ (64,101) | $ (228,478) | $ (35,919) |
Net Cash Provided by Operating Activities | $ (178,293) | $ 244,815 | ||
Return of shares from related party | 12,208,432 |
Summary of Significant Accounting Policies (Details)
|
6 Months Ended | |
---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Billing Concentrations | ||
A | 20.00% | 11.00% |
B | 15.00% | 13.00% |
C | 13.00% | 1.00% |
D | 13.00% | |
E | 17.00% | |
Vendor concentrations | ||
A | 65.00% | 6.00% |
B | 15.00% | 35.00% |
C | 1.00% | 35.00% |
Derivative Liabilities (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
Summary of fair value of the conversion feature |
|
|||||||||||||||||||||||||||||||||||||||||||||
Fair value at the commitment and re-measurement dates for the Company’s derivative liabilities |
|
Stock Warrants (Details 1) (Warrant [Member], USD $)
|
6 Months Ended | |
---|---|---|
Jun. 30, 2012
|
Dec. 31, 2011
|
|
Warrant [Member]
|
||
Summary of all outstanding and exercisable warrants | ||
Exercise Price | $ 0.40 | |
Warrants Outstanding | 15,000 | 15,000 |
Warrants Exercisable | 15,000 | |
Weighted Average Remaining Contractual Life | 2 years 4 months 28 days | |
Aggregate Intrinsic Value | $ 300 |
Debt (Details 1) (USD $)
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Note Secured | |
Balance | |
Reclassification from accounts payable to notes payable | 51,290 |
Repayments | (21,370) |
Balance, ending | $ 29,920 |
Accounts Receivable (Details) (USD $)
|
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Accounts receivable | ||
Gross accounts receivable | $ 1,353,439 | $ 1,057,696 |
Allowance | (67,682) | (50,861) |
Accounts receivable – net | $ 1,285,757 | $ 1,006,835 |
Commitments and Contingencies (Details Textual) (USD $)
|
6 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Dec. 31, 2011
|
Oct. 06, 2011
|
Jul. 01, 2011
|
Jan. 11, 2011
|
Nov. 15, 2010
|
|
Commitments and Contingencies (Textual) | |||||||
Approximate leased space of company, (In square feet) | 3,100 | 4,200 | 5,100 | 1,200 | |||
Execution period of lease | 5 years | 5 years | 10 years | 2 years | |||
Rent expense on lease | $ 125,823 | $ 53,512 | |||||
Deferred rent payable | $ 32,387 | $ 17,535 |
Derivative Liabilities (Details) (USD $)
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Summary of fair value of the conversion feature | |
Derivative liability - December 31, 2011 | |
Fair value at the commitment date for debt instruments | 244,153 |
Fair value mark to market adjustment for debt instruments | (15,945) |
Derivative liability – June 30,2012 | $ 228,208 |
Accounts Receivable
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||
Accounts Receivable | Note 3 Accounts Receivable
Accounts receivable consisted of the following at June 30, 2012 and December 31, 2011.
The Company recorded an approximate 5% allowance for bad debt for estimated differences between expected and actual payment of accounts receivables. These reductions are made based upon estimates that are determined by historical experience, contractual terms, and current conditions. Each quarter, the Company reevaluates its estimates to assess the adequacy of its allowance, adjusting the amounts as necessary.
In addition, for the six months ended June 30, 2012 the Company wrote off $38,311 of its accounts receivable to bad debt expense; there we no bad debt write-offs during the six months ended June 30, 2011.
|